Fed Bioequivalence Study of Fenofibric Acid Versus TriCor® (Fenofibrate)
NCT00960687
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
54
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Fenofibric Acid (Fibricor™) 105 mg Tablet
DRUG:
Fenofibrate (Tricor®) 145 mg Tablet
Sponsor
Mutual Pharmaceutical Company, Inc.